Michael Caulfield

Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD.

Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.

Abington Friends School provides primary and secondary education services. The company was founded in 1697 by John Barnes and is headquartered in Jenkintown, PA.

Orphan Technologies Ltd. engages in the manufacturing of biopharmaceutical drugs. It develops novel therapies for patients suffering from rare disorder and classical homocystinuria. The company is headquartered in Rapperswil, Switzerland.

HCU Network America provides support services for patients and families. The non-profit company is based in Lisle, IL.

Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA.

Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA.

Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA.

Wyeth Canada ULC manufactures and distributes pharmaceutical products. The company markets products in the areas of women's health care, neuroscience, musculoskeletal therapy, transplantation and immunology, hemophilia, and vaccines. It was founded in 1907 and is headquartered in Markham, Canada.

Bowdoin College is an independent, nonsectarian, coeducational residential, undergraduate liberal arts institution founded in 1794. It is located in Brunswick, ME.

Michel Greco SA provides postal, courier, and express services. The private company is based in Luxembourg, Luxembourg. The Luxembourger company was founded in 1987 by Michel Gréco.

Immutep SAS specializes in biotechnology research and development. It develops immunotherapy treatments for cancer and autoimmune diseases. The company was founded by Frédéric Triebel on October 17, 2001 and is headquartered Orsay, France.

The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.

Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France.

Texcell SA is a contract research organization that provides services for viral clearances, viral safety testing, and the manufacture of GMP cell banks to pharmaceutical companies and bioventures. The private company is based in France and has subsidiaries in various locations, including the United States. The French company has offices and laboratories in various locations around the world, including France, the United States, and Japan. The company's capabilities include in vivo, in vitro, toxicology, immunotoxicity, and immunogenicity testing, as well as CGMP cell banking and preparation of fully characterized virus stocks. Texcell has recently strengthened its activities to face the growing demand for tests related to COVID-19. The company is developing new innovative tests and new protocols in molecular biology and immunology.

ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada.

Noraker SARL designs, produces and markets synthetic and absorbable biomaterial-based implantable medical devices. It offers dental surgery and orthopedic products. The firm's services include filling bone defects such as cyst and dental granuloma. The company was founded by Rachid Zenati in 2005 and is headquartered in Villeurbanne, France.

Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK